| Complete regression of metastatic cervical cancer after treatment with human papillomavirus–targeted tumor-infiltrating T cells S Stevanović, LM Draper, MM Langhan, TE Campbell, ML Kwong, ... Journal of Clinical Oncology 33 (14), 1543, 2015 | 794 | 2015 |
| Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer S Stevanović, A Pasetto, SR Helman, JJ Gartner, TD Prickett, B Howie, ... Science 356 (6334), 200-205, 2017 | 376 | 2017 |
| A phase II study of tumor-infiltrating lymphocyte therapy for human papillomavirus–associated epithelial cancers S Stevanović, SR Helman, JR Wunderlich, MM Langhan, SL Doran, ... Clinical Cancer Research 25 (5), 1486-1493, 2019 | 223 | 2019 |
| T-cell receptor gene therapy for human papillomavirus–associated epithelial cancers: a first-in-human, phase I/II study SL Doran, S Stevanović, S Adhikary, JJ Gartner, L Jia, MLM Kwong, ... Journal of Clinical Oncology 37 (30), 2759, 2019 | 203 | 2019 |
| Tumor-infiltrating human CD4+ regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivity M Ahmadzadeh, A Pasetto, L Jia, DC Deniger, S Stevanović, PF Robbins, ... Science immunology 4 (31), eaao4310, 2019 | 197 | 2019 |
| TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers NB Nagarsheth, SM Norberg, AL Sinkoe, S Adhikary, TJ Meyer, JB Lack, ... Nature medicine 27 (3), 419-425, 2021 | 196 | 2021 |
| Targeting of HPV-16+ epithelial cancer cells by TCR gene engineered T cells directed against E6 LM Draper, MLM Kwong, A Gros, S Stevanović, E Tran, S Kerkar, ... Clinical Cancer Research 21 (19), 4431-4439, 2015 | 183 | 2015 |
| Targeting liposomes with protein drugs to the blood–brain barrier in vitro CC Visser, S Stevanović, LH Voorwinden, L van Bloois, PJ Gaillard, ... European journal of pharmaceutical sciences 25 (2-3), 299-305, 2005 | 152 | 2005 |
| Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model BY Jin, TE Campbell, LM Draper, S Stevanović, B Weissbrich, Z Yu, ... JCI insight 3 (8), 2018 | 140 | 2018 |
| Validation of the Transferrin Receptor for Drug Targeting to Brain Capillary Endothelial Cells In Vitro CC Visser, S Stevanović, L Heleen Voorwinden, PJ Gaillard, ... Journal of drug targeting 12 (3), 145-150, 2004 | 112 | 2004 |
| HLA class II upregulation during viral infection leads to HLA-DP–directed graft-versus-host disease after CD4+ donor lymphocyte infusion S Stevanović, CAM van Bergen, SAP van Luxemburg-Heijs, ... Blood, The Journal of the American Society of Hematology 122 (11), 1963-1973, 2013 | 88 | 2013 |
| Circulating cell-free DNA for metastatic cervical cancer detection, genotyping, and monitoring Z Kang, S Stevanović, CS Hinrichs, L Cao Clinical Cancer Research 23 (22), 6856-6862, 2017 | 83 | 2017 |
| Treatment of plasma cell dyscrasias with lenalidomide MA Dimopoulos, E Kastritis, SV Rajkumar Leukemia 22 (7), 1343-1353, 2008 | 48 | 2008 |
| HPV-targeted tumor-infiltrating lymphocytes for cervical cancer. CS Hinrichs, S Stevanovic, L Draper, R Somerville, J Wunderlich, ... Journal of Clinical Oncology 32 (15_suppl), LBA3008-LBA3008, 2014 | 41 | 2014 |
| Human allo-reactive CD4+ T cells as strong mediators of anti-tumor immunity in NOD/scid mice engrafted with human acute lymphoblastic leukemia S Stevanović, M Griffioen, BA Nijmeijer, MLJ van Schie, AN Stumpf, ... Leukemia 26 (2), 312-322, 2012 | 40 | 2012 |
| A phase I/II clinical trial of E6 T-cell receptor gene therapy for human papillomavirus (HPV)-associated epithelial cancers. CS Hinrichs, SL Doran, S Stevanovic, S Adhikary, M Mojadidi, ML Kwong, ... Journal of Clinical Oncology 35 (15_suppl), 3009-3009, 2017 | 34 | 2017 |
| Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung Cancer Antigen-1 B Marcinkowski, S Stevanović, SR Helman, SM Norberg, C Serna, B Jin, ... Journal for immunotherapy of cancer 7, 1-9, 2019 | 30 | 2019 |
| HLA-class II disparity is necessary for effective T cell mediated Graft-versus-Leukemia effects in NOD/scid mice engrafted with human acute lymphoblastic leukemia S Stevanović, MLJ van Schie, M Griffioen, JH Falkenburg Leukemia 27 (4), 985-987, 2013 | 17 | 2013 |
| Genetically engineered T-cell therapy for HPV-associated epithelial cancers: A first in human, phase I/II clinical trial. SL Doran, S Stevanovic, S Adhikary, JJ Gartner, L Jia, MLM Kwong, ... Journal of Clinical Oncology 36 (15_suppl), 3019-3019, 2018 | 10 | 2018 |
| 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016 A Lundqvist, V van Hoef, X Zhang, E Wennerberg, J Lorent, K Witt, ... Journal for immunotherapy of cancer 4, 1-106, 2016 | 10 | 2016 |
